Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables
暂无分享,去创建一个
W. Herzog | D. Schellberg | S. Kraemer | C. Zugck | J. Juenger | W Herzog | D Schellberg | M. Haass | J Juenger | S Kraemer | A Haunstetter | C Zugck | M Haass | A. Haunstetter | W. Herzog
[1] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[2] J. Hulot,et al. Beta‐blocker treatment in heart failure , 2001, Fundamental & clinical pharmacology.
[3] P. Jones,et al. The left ventricular dysfunction questionnaire (LVD-36): reliability, validity, and responsiveness , 2000, Heart.
[4] A. Steptoe,et al. Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy , 2000, Heart.
[5] S. Gerber,et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? , 2000, European heart journal.
[6] J. Spertus,et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.
[7] K. Werdan,et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. , 2000, European heart journal.
[8] L. Tavazzi,et al. Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity. , 1999, European heart journal.
[9] S. Svebak,et al. Depressed Mood and Subjective Health Symptoms as Predictors of Mortality in Patients with Congestive Heart Failure: A Two-Years Follow-up Study , 1999, International journal of psychiatry in medicine.
[10] E. Havranek,et al. Prevalence of depression in congestive heart failure. , 1999, The American journal of cardiology.
[11] J. Cohn. Improving Outcomes in Congestive Heart Failure: Val-HeFT , 1999, Cardiology.
[12] B. Phillips,et al. Improving outcomes in congestive heart failure. , 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[13] L. Abramson,et al. Depressogenic cognitive styles: predictive validity, information processing and personality characteristics, and developmental origins. , 1999, Behaviour research and therapy.
[14] H. Thomas,et al. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis , 1998, Hepatology.
[15] W. Herzog,et al. QUALITY OF LIFE, ANXIETY AND DEPRESSION DEPENDENT ON NYHA-CLASS IN PATIENTS WITH CHRONIC HEART FAILURE , 1998 .
[16] Monika Bullinger,et al. SF-36, Fragebogen zum Gesundheitszustand , 1998 .
[17] A. Maisel,et al. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. , 1998, American heart journal.
[18] Milton Packer,et al. Safety and efficacy of carvedilol in severe heart failure , 1997 .
[19] A. Steptoe,et al. Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. , 1997, Heart.
[20] S. Leeder,et al. Burden and outcomes of hospitalisation for congestive heart failure , 1997, The Medical journal of Australia.
[21] F. Dekker,et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] M. Bullinger. [Health related quality of life and subjective health. Overview of the status of research for new evaluation criteria in medicine]. , 1997, Psychotherapie, Psychosomatik, medizinische Psychologie.
[23] F. Dekker,et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] J. Cohn,et al. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. , 1997, Journal of cardiac failure.
[25] S. Kubo. Effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. , 1997, Cardiology.
[26] C. Jenkinson,et al. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). , 1997, Age and ageing.
[27] J. Wilson,et al. Circulatory status and response to cardiac rehabilitation in patients with heart failure. , 1996, Circulation.
[28] D. Bates,et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. , 1996, The American journal of medicine.
[29] H. Oral,et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.
[30] S. Yusuf,et al. Effects of exercise training in patients with congestive heart failure: a critical review. , 1995, Journal of the American College of Cardiology.
[31] G. Guyatt. Measurement of health-related quality of life in heart failure. , 1993, Journal of the American College of Cardiology.
[32] J. Cohn,et al. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. , 1993, The American journal of cardiology.
[33] R. Niaura,et al. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. , 1993, The American journal of cardiology.
[34] C. McHorney,et al. The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.
[35] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[36] L. Stevenson,et al. Quality of life in patients with advanced heart failure. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[37] M. Brodsky,et al. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group. , 1992, Circulation.
[38] Ware J.E.Jr.,et al. THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .
[39] A. Stewart,et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. , 1989, JAMA.
[40] G. Metalsky,et al. Hopelessness depression: A theory-based subtype of depression. , 1989 .
[41] William H. Rogers,et al. Functional Status and Well-Being of Patients with Chronic Conditions , 1989 .
[42] N. Wenger. Quality of life: can it and should it be assessed in patients with heart failure? , 1989, Cardiology.
[43] T. Rector. Patients' self-assessment of their congestive heart failure : Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire , 1987 .
[44] G. Guyatt,et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.
[45] C. Furberg,et al. Assessment of quality of life in clinical trials of cardiovascular therapies. , 1984, The American journal of cardiology.